Skip to main content

MSF challenges Pfizer patent in India

MSF challenges Pfizer patent in India

Doctors Without Borders (MSF) has filed a ‘patent opposition’ in India to block US pharmaceutical company Pfizer from patenting its pneumonia vaccine, PCV13.

MSF believes the company’s priority focuses on trying to guarantee market monopoly rather than providing life-saving vaccine to the most vulnerable.

This is the first time granting a patent in India has been challenged by a medical organisation. If MSF wins, it opens the way for affordable versions of the vaccine to be made available to developing countries and humanitarian organisations.

For the full article from MSF, for the following link.

 

Share